Collegium Pharmaceutical
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
COLL Key Statistics
Stock Snapshot
The current Collegium Pharmaceutical(COLL) stock price is $34.07, with a market capitalization of 1.1B. The stock trades at a price-to-earnings (P/E) ratio of 16.68.
During the trading session on 2026-05-25, Collegium Pharmaceutical(COLL) shares reached a daily high of $35.01 and a low of $33.98. At a current price of $34.07, the stock is +0.3% higher than the low and still -2.7% under the high.
Trading volume for Collegium Pharmaceutical(COLL) stock has reached 161.12K, versus its average volume of 367.94K.
The stock's 52-week range extends from a low of $28.34 to a high of $50.79.
The stock's 52-week range extends from a low of $28.34 to a high of $50.79.
COLL News
Collegium Pharmaceutical recently reported first-quarter 2026 net income of US$14.5 million, a sharp increase from US$2.42 million a year earlier, reaffirmed it...
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.